fda

AMA Update 85: Andrea Garcia, JD, MPH, shares vaccine updates on boosters and young children

AMA CXO Todd Unger talks with AMA’s Director of Science, Medicine and Public Health, Andrea Garcia, about trending topics related to the pandemic over the past week. Also covering Pfizer’s announcement regarding vaccine effectiveness in 5-11 year olds, the FDA’s decision on booster shots, and a state-by-state look at swings in COVID case count.

Read More

AMA Update 82: The FDA’s Dr. John Farley talks about why ivermectin should not be used to prevent or treat COVID

A discussion with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA, about what physicians and patients really need to know about ivermectin.

Read More

AMA Update 76: AMA President Gerald Harmon, MD, discusses FDA’s full approval of Pfizer vaccine

AMA president and family medicine specialist, Dr. Gerald Harmon, dives into the details about the FDA’s full approval of the Pfizer vaccine—and what it means for physicians and patients.  

Read More